| Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models M Hadla, S Palazzolo, G Corona, I Caligiuri, V Canzonieri, G Toffoli, ... Nanomedicine 11 (18), 2431-2441, 2016 | 252 | 2016 |
| Inorganic nanoparticles for cancer therapy: a transition from lab to clinic S Bayda, M Hadla, S Palazzolo, P Riello, G Corona, G Toffoli, F Rizzolio Current medicinal chemistry 25 (34), 4269-4303, 2018 | 210 | 2018 |
| The clinical translation of organic nanomaterials for cancer therapy: a focus on polymeric nanoparticles, micelles, liposomes and exosomes S Palazzolo, S Bayda, M Hadla, I Caligiuri, G Corona, G Toffoli, F Rizzolio Current medicinal chemistry 25 (34), 4224-4268, 2018 | 168 | 2018 |
| Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin G Toffoli, M Hadla, G Corona, I Caligiuri, S Palazzolo, S Semeraro, ... Nanomedicine 10 (19), 2963-2971, 2015 | 136 | 2015 |
| Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy S Bayda, M Hadla, S Palazzolo, V Kumar, I Caligiuri, E Ambrosi, ... Journal of Controlled Release 248, 144-152, 2017 | 72 | 2017 |
| An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy S Palazzolo, M Hadla, C Russo Spena, I Caligiuri, R Rotondo, M Adeel, ... Cancers 11 (12), 1997, 2019 | 46 | 2019 |
| Proof-of-concept multistage biomimetic liposomal DNA origami nanosystem for the remote loading of doxorubicin S Palazzolo, M Hadla, CR Spena, S Bayda, V Kumar, F Lo Re, M Adeel, ... ACS medicinal chemistry letters 10 (4), 517-521, 2019 | 44 | 2019 |
| Enhanced chemotherapeutic behavior of open‐caged DNA@ doxorubicin nanostructures for cancer cells V Kumar, S Bayda, M Hadla, I Caligiuri, C Russo Spena, S Palazzolo, ... Journal of Cellular Physiology 231 (1), 106-110, 2016 | 38 | 2016 |
| Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications G Sponchia, E Ambrosi, F Rizzolio, M Hadla, A Del Tedesco, CR Spena, ... Journal of materials chemistry B 3 (36), 7300-7306, 2015 | 35 | 2015 |
| Cancer extracellular vesicles: next-generation diagnostic and drug delivery nanotools S Palazzolo, L Memeo, M Hadla, F Duzagac, A Steffan, T Perin, ... Cancers 12 (11), 3165, 2020 | 25 | 2020 |
| Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients R Rovito, V Bono, M Augello, C Tincati, F Mainoldi, G Beaudoin-Bussières, ... Scientific Reports 12 (1), 19658, 2022 | 11 | 2022 |
| Effect of quorum sensing M Hadla, MA Halabi Comprehensive Analytical Chemistry 81, 95-116, 2018 | 10 | 2018 |
| Growth differentiation factor 15 (GDF-15) levels associate with lower survival in chronic kidney disease patients with COVID-19 A Galassi, P Ciceri, V Bono, L Magagnoli, M Sala, L Artioli, R Rovito, ... Biomedicines 10 (12), 3251, 2022 | 5 | 2022 |
| Exosomal encapsulation of doxorubicin reduces the cardiac toxicity of mice F Rizzolio, M Hadla, G Corona, I Caligiuri, S Palazzolo, S Semeraro, ... Cancer Research 76 (14_Supplement), 2205-2205, 2016 | 3 | 2016 |
| Activation of PIEZO1 Inhibits Kidney Cystogenesis Q Fan, M Hadla, Z Peterson, G Nelson, H Ye, X Wang, JM Mardirossian, ... bioRxiv, 2024.05. 11.593717, 2024 | | 2024 |
| MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection (vol 37, gfac070. 023, 2022) P Ciceri, V Bono, L Magagnoli, M Sala, L Artioli, R Rovito, M Hadla, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 37 (11), 2295-2295, 2022 | | 2022 |
| MO409: GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection P Ciceri, V Bono, L Magagnoli, M Sala, L Artioli, R Rovito, M Hadla, ... Nephrology Dialysis Transplantation 37 (Supplement_3), gfac070. 023, 2022 | | 2022 |
| GDF-15 is a Predictor of Mortality in Chronic Kidney Disease Patients With Covid-19 Infection P Ciceri, V Bono, L Magagnoli, M Sala, L Artioli, R Rovito, M Hadla, ... Nephrology, dialysis, transplantation: official publication of the European …, 2022 | | 2022 |
| SARS-CoV-2 PLASMA VIREMIA and DYSREGULATED IMMUNITY in SEVERE COVID-19 R Rovito, V Bono, M Augello, C Tincati, F Mainoldi, G Beaudoin-Bussières, ... Topics in Antiviral Medicine, 72-73, 2022 | | 2022 |
| GDF-15 AS A PREDICTOR of MORTALITY in COVID-19: IMPLICATIONS for TREATMENT V Bono, P Ciceri, M Sala, L Magagnoli, R Rovito, L Artioli, M Hadla, ... Topics in Antiviral Medicine, 77-78, 2022 | | 2022 |
